Insider · CIK 0001940120

Lee Tien-Li

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001940120

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-09	AARDAardvark Therapeutics, Inc. · Stock option (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	−204K sh	—	—	203,851
2025-12-11	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+7,000 sh	$14.48	+$101K	1,551,613
2025-10-15	AARDAardvark Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+1,229 sh	$4.24	+$5,210.96	1,544,613
2025-10-15	AARDAardvark Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−1,229 sh	—	—	40,566
2025-09-15	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+6,500 sh	$9.51	+$61.8K	1,539,884
2025-09-15	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+3,500 sh	$9.94	+$34.8K	1,543,384
2025-09-12	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$8.50	+$42.5K	1,533,384
2025-09-11	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+6,000 sh	$7.82	+$46.9K	1,528,384
2025-09-10	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+9,000 sh	$7.91	+$71.2K	1,522,384
2025-08-28	AARDAardvark Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+17.2K sh	$4.24	+$73K	1,513,384
2025-08-28	AARDAardvark Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−17.2K sh	—	—	41,795
2025-06-11	AARDAardvark Therapeutics, Inc. · Stock option (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+550K sh	—	—	549,534
2025-02-14	AARDAardvark Therapeutics, Inc.C Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	+41.3K sh	—	—	1,479,633
2025-02-14	AARDAardvark Therapeutics, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+16.5K sh	$16.00	+$265K	1,496,175
2025-02-14	AARDAardvark Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	−350K sh	—	—	0
2023-01-17	SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Feb 114
Lee Tien-Li0001193125-26-047316
SEC(opens sec.gov)
Dec 124
Lee Tien-Li0001193125-25-318069
SEC(opens sec.gov)
Oct 164
Lee Tien-Li0001193125-25-241647
SEC(opens sec.gov)
Sep 164
Lee Tien-Li0001193125-25-204233
SEC(opens sec.gov)
Sep 124
Lee Tien-Li0001193125-25-202490
SEC(opens sec.gov)
Aug 294
Lee Tien-Li0001193125-25-192747
SEC(opens sec.gov)
Jun 134
Lee Tien-Li0000950170-25-086147
SEC(opens sec.gov)
Feb 194
Lee Tien-Li0000950170-25-023253
SEC(opens sec.gov)
Jan 174
Lee Tien-Li0000899243-23-001880
SEC(opens sec.gov)

Companies

Address

C/O AARDVARK THERAPEUTICS, INC. 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050

SAN DIEGO, CA, 92122